| Jean Everly Lafontant, MD | |
|
5870 Arlington Ave, Riverside, CA 92504-2037 | |
| (951) 683-6596 | |
| (951) 683-4239 |
| Full Name | Jean Everly Lafontant |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine |
| Experience | 28 Years |
| Location | 5870 Arlington Ave, Riverside, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043501851 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | A131224 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bgm Medical Services Inc A Medical Corporation | 3577956051 | 2 |
News Archive
IMRIS Inc. today announced the sale of IMRISneuro to Dartmouth-Hitchcock Medical Center ("DHMC") in Lebanon, New Hampshire.
Javier Buceta, associate professor of bioengineering, Paolo Bocchini, associate professor of civil and environmental engineering, and postdoctoral student Graziano Fiorillo of Lehigh University have created a modeling framework that takes a zoonotic perspective on Ebola.
A novel electronic device designed to "zap" away migraine pain before it starts has proven to be the next form of relief for those suffering from the debilitating disease, according to a study conducted at The Ohio State University Medical Center.
In 40 years of smoking, Katie Kennedy has tried four times to quit but always went back to cigarettes. Today, she is summoning a new mental image when a craving comes on: rows of COVID-19 patients hooked to ventilators.
The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.
› Verified 9 days ago
| Entity Name | Parkview Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114339207 PECOS PAC ID: 0345565925 Enrollment ID: O20150203001408 |
News Archive
IMRIS Inc. today announced the sale of IMRISneuro to Dartmouth-Hitchcock Medical Center ("DHMC") in Lebanon, New Hampshire.
Javier Buceta, associate professor of bioengineering, Paolo Bocchini, associate professor of civil and environmental engineering, and postdoctoral student Graziano Fiorillo of Lehigh University have created a modeling framework that takes a zoonotic perspective on Ebola.
A novel electronic device designed to "zap" away migraine pain before it starts has proven to be the next form of relief for those suffering from the debilitating disease, according to a study conducted at The Ohio State University Medical Center.
In 40 years of smoking, Katie Kennedy has tried four times to quit but always went back to cigarettes. Today, she is summoning a new mental image when a craving comes on: rows of COVID-19 patients hooked to ventilators.
The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.
› Verified 9 days ago
| Entity Name | Bawj Medical Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457864464 PECOS PAC ID: 4284974403 Enrollment ID: O20190325002098 |
News Archive
IMRIS Inc. today announced the sale of IMRISneuro to Dartmouth-Hitchcock Medical Center ("DHMC") in Lebanon, New Hampshire.
Javier Buceta, associate professor of bioengineering, Paolo Bocchini, associate professor of civil and environmental engineering, and postdoctoral student Graziano Fiorillo of Lehigh University have created a modeling framework that takes a zoonotic perspective on Ebola.
A novel electronic device designed to "zap" away migraine pain before it starts has proven to be the next form of relief for those suffering from the debilitating disease, according to a study conducted at The Ohio State University Medical Center.
In 40 years of smoking, Katie Kennedy has tried four times to quit but always went back to cigarettes. Today, she is summoning a new mental image when a craving comes on: rows of COVID-19 patients hooked to ventilators.
The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.
› Verified 9 days ago
| Entity Name | Bgm Medical Services Inc A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780356790 PECOS PAC ID: 3577956051 Enrollment ID: O20220204000946 |
News Archive
IMRIS Inc. today announced the sale of IMRISneuro to Dartmouth-Hitchcock Medical Center ("DHMC") in Lebanon, New Hampshire.
Javier Buceta, associate professor of bioengineering, Paolo Bocchini, associate professor of civil and environmental engineering, and postdoctoral student Graziano Fiorillo of Lehigh University have created a modeling framework that takes a zoonotic perspective on Ebola.
A novel electronic device designed to "zap" away migraine pain before it starts has proven to be the next form of relief for those suffering from the debilitating disease, according to a study conducted at The Ohio State University Medical Center.
In 40 years of smoking, Katie Kennedy has tried four times to quit but always went back to cigarettes. Today, she is summoning a new mental image when a craving comes on: rows of COVID-19 patients hooked to ventilators.
The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jean Everly Lafontant, MD 5870 Arlington Ave, Riverside, CA 92504-2037 Ph: (952) 683-6596 | Jean Everly Lafontant, MD 5870 Arlington Ave, Riverside, CA 92504-2037 Ph: (951) 683-6596 |
News Archive
IMRIS Inc. today announced the sale of IMRISneuro to Dartmouth-Hitchcock Medical Center ("DHMC") in Lebanon, New Hampshire.
Javier Buceta, associate professor of bioengineering, Paolo Bocchini, associate professor of civil and environmental engineering, and postdoctoral student Graziano Fiorillo of Lehigh University have created a modeling framework that takes a zoonotic perspective on Ebola.
A novel electronic device designed to "zap" away migraine pain before it starts has proven to be the next form of relief for those suffering from the debilitating disease, according to a study conducted at The Ohio State University Medical Center.
In 40 years of smoking, Katie Kennedy has tried four times to quit but always went back to cigarettes. Today, she is summoning a new mental image when a craving comes on: rows of COVID-19 patients hooked to ventilators.
The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.
› Verified 9 days ago
Brandy Liu, D.O. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 4193 Flat Rock Dr Ste 200, Riverside, CA 92505 Phone: 626-208-9377 | |
Gerald I. West Jr., MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 909-353-2000 | |
Dr. Cesar Reis, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 833-574-2273 | |
Dr. Marc Jean-paul Debay, M.D. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 3390 University Ave Ste 100, Riverside, CA 92501 Phone: 844-827-8000 | |
Howard Paul Waters Jr., M.D. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 6485 Day St Ste 302, Riverside, CA 92507 Phone: 951-653-5291 Fax: 951-653-2440 | |
Dr. Ting-wei Ou, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1760 Chicago Ave Ste J3, Riverside, CA 92507 Phone: 951-781-2200 Fax: 951-781-2220 |